Cholesterol Homeostasis in Human Brain: Evidence for an Age-dependent Flux of 24S-hydroxycholesterol from the Brain into the Circulation
Overview
Affiliations
We have investigated whether side chain-hydroxylated cholesterol species are important for elimination of cholesterol from the brain. Plasma concentrations of 24-hydroxycholesterol (24-OH-Chol) in the internal jugular vein and the brachial artery in healthy volunteers were consistent with a net flux of this steroid from the brain into the circulation, corresponding to elimination of approximately 4 mg cholesterol during a 24-h period in adults. Results of experiments with rats exposed to 18O2 were also consistent with a flux of 24-OH-Chol from the brain into the circulation. No other oxysterol measured showed a similar behavior as 24-OH-Chol. These results and the finding that the concentration of 24-OH-Chol was 30- to 1500-fold higher in the brain than in any other organ except the adrenals indicate that the major part of 24-OH-Chol present in the circulation originates from the brain. Both the 24-OH-Chol present in the brain and in the circulation were the 24S-stereoisomer. In contrast to other oxysterols, levels of plasma 24-OH-Chol were found to be markedly dependent upon age. The ratio between 24-OH-Chol and cholesterol in plasma was approximately 5 times higher during the first decade of life than during the sixth decade. There was a high correlation between levels of 24-OH-Chol in plasma and cerebrospinal fluid. It is suggested that the flux of 24-OH-Chol from the brain is important for cholesterol homeostasis in this organ.
The Cross-Talk Between the Peripheral and Brain Cholesterol Metabolisms.
Savulescu-Fiedler I, Dorobantu-Lungu L, Dragosloveanu S, Benea S, Dragosloveanu C, Caruntu A Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996836 PMC: 11853762. DOI: 10.3390/cimb47020115.
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson's disease.
Dai L, Wang J, Meng L, Zhang X, Xiao T, Deng M PLoS Biol. 2025; 23(2):e3002974.
PMID: 39964974 PMC: 11835240. DOI: 10.1371/journal.pbio.3002974.
Lu D, Wang F, Yang Y, Duan A, Ren Y, Feng Y Heliyon. 2025; 11(1):e41601.
PMID: 39866460 PMC: 11757779. DOI: 10.1016/j.heliyon.2024.e41601.
Fragment-based development of small molecule inhibitors targeting cholesterol metabolism.
Kavanagh M, McLean K, Gilbert S, Amadi C, Snee M, Tunnicliffe R bioRxiv. 2025; .
PMID: 39803573 PMC: 11722527. DOI: 10.1101/2024.10.28.620643.
Petkova-Kirova P, Kolchina A, Baas S, Wagenpfeil G, Unger M, Schulze-Hentrich J Front Pharmacol. 2024; 15:1477009.
PMID: 39403150 PMC: 11472000. DOI: 10.3389/fphar.2024.1477009.